A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study

NCT03693625 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
31
Enrollment
INDUSTRY
Sponsor class

Stopped Recruitment was stopped after an interim analysis of the parent GS39684 study.

Conditions

Interventions

Sponsor

Genentech, Inc.